Hypoferremia reduces long-term risk of major adverse cardiovascular events after STEMI by averting the myocardial reactive iron storm
Vera-Aviles, M.; Kabir, S.; Christodoulou, M. D.; Shanmuganathan, M.; Kotronias, R.; Cleland, J.; Channon, K. M.; Lakhal-Littleton, S.
Show abstract
Background and aimsIron deficiency (ID) is common in patients with acute STEMI. ID has previously been associated with either adverse or favourable effects, depending on the definition of ID, sampling timepoint, outcome measures and follow-up duration. This study systematically addresses the impact of ID on long-term outcomes and explores the underlying mechanisms. MethodsPatients with acute STEMI (n=167) were followed for 4.5 years for major adverse cardiovascular events (MACE), including new HF diagnosis, recurrent MI or cardiac death. Iron markers were sampled at presentation and later timepoints. Myocardial injury was assessed by CMR at 2 days and 6 months. Mechanisms underlying clinical findings were evaluated in a mouse model of MI. ResultsID, by any definition, was common in acute STEMI patients at presentation. Hypoferremia (Tsat<20% or iron<13uM) but not hypoferritinemia (ferritin<100ug/L) predicted lower risk of MACE. Hypoferremia predicted lower troponin, acute myocardial T1, LVESV and LVEDV at 2 days, but lower myocardial salvage at 6 months. Iron status sampled from 6 hours after presentation was no longer associated with MACE. In mice, MI rapidly triggered a myocardial reactive iron storm, early LV remodelling, and eventually HF. These effects were averted by iron restriction. ConclusionsThis study reveals that hypoferremia in acute STEMI exerts both favourable and adverse effects, that nonetheless translate into better long-term clinical outcomes. This research reconciles previous seemingly conflicting reports. It also highlights a potential stepwise approach of acute iron chelation to reduce myocardial injury, followed days later by iron supplementation to promote myocardial salvage. O_FIG O_LINKSMALLFIG WIDTH=140 HEIGHT=200 SRC="FIGDIR/small/25320244v2_ufig1.gif" ALT="Figure 1"> View larger version (47K): org.highwire.dtl.DTLVardef@3242baorg.highwire.dtl.DTLVardef@1baf6c7org.highwire.dtl.DTLVardef@19fa173org.highwire.dtl.DTLVardef@120be45_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Agrin promotes coordinated therapeutic processes leading to improved cardiac repair in pigs 96%
- CD206 + IL-4Rα + MACROPHAGES ARE DRIVERS OF ADVERSE CARDIAC REMODELING IN ISCHEMIC CARDIOMYOPATHY 94%
- Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization Study 94%
Similar papers in this journal
- Development and validation of imaging-free myocardial fibrosis prediction models, association with outcomes, and sample size estimation for phase 3 trials 95%
- Mineralocorticoid Receptor Antagonism Reduces Atrial Arrhythmias Post-Cardiac Surgery and Attenuates Atrial Stress Responses to Cardioplegic Arrest 93%
- The Cell Surface Receptors Ror1/2 Control Cardiac Myofibroblast Differentiation 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.